Addex Therapeutics (ADXN) FCF Margin (2019 - 2025)
Addex Therapeutics' (ADXN) quarterly FCF Margin came in at 249744.35% in Q4 2025, down 43200443.0% year-over-year from N/an in Q4 2024, and down 13822.28% quarter-over-quarter from 1793.85% in Q3 2025.
Powered by 
Analysis
Addex Therapeutics (ADXN) FCF Margin (2019 - 2025) Analysis & Trends
Addex Therapeutics has disclosed FCF Margin across 7 years of filings, most recently posting 249744.35% for Q4 2025.
- In Q4 2025, FCF Margin fell 43200443.0% year-over-year to 249744.35%; the TTM figure through Dec 2025 stood at 6671.42% (down 604257.0% YoY), while the FY2025 annual figure was 62928.42%, down 6079276.0% from the prior year.
- FCF Margin came in at 249744.35% for Q4 2025 at Addex Therapeutics, down from 1793.85% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 182260.08% in Q4 2024 to a low of 249744.35% in Q4 2025.
- Average FCF Margin over 5 years is 5034.22%, with a median of 713.66% recorded in 2023.
- Year-over-year, FCF Margin surged 18746407 bps in 2024 and slumped 43200443 bps in 2025.
- Over 5 years, FCF Margin stood at 465.39% in 2021, then sank by 496 bps to 2774.44% in 2022, then sank by 88 bps to 5203.99% in 2023, then surged by 3602 bps to 182260.08% in 2024, then slumped by 237 bps to 249744.35% in 2025.
- Per Business Quant data, the three most recent FCF Margin figures were 249744.35% in Q4 2025, 1793.85% in Q3 2025, and 182260.08% in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 43.05% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 2.01% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 25.52% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 29.58% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 26.25% |
| 10 | Addex Therapeutics | 3.27 Mn | 3.27 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -249,744.35% |
| Sep 30, 2025 | -1,793.85% |
| Dec 31, 2024 | 182,260.08% |
| Sep 30, 2024 | -740.35% |
| Jun 30, 2024 | -2,391.66% |
| Mar 31, 2024 | -939.86% |
| Dec 31, 2023 | -5,203.99% |
| Sep 30, 2023 | -686.98% |
| Jun 30, 2023 | -436.75% |
| Mar 31, 2023 | -470.55% |
| Dec 31, 2022 | -2,774.44% |
| Sep 30, 2022 | -657.01% |
| Jun 30, 2022 | -3,179.79% |
| Mar 31, 2022 | -2,042.10% |
| Dec 31, 2021 | -465.39% |
| Sep 30, 2021 | -370.46% |
| Jun 30, 2021 | -650.92% |
| Mar 31, 2021 | -327.61% |
| Dec 31, 2020 | -312.47% |
| Sep 30, 2020 | -9,379.36% |